methionine sulfoximine has been researched along with perfosfamide in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bigner, DD; Bullock, N; Colvin, OM; Friedman, HS; Griffith, OW; Kaufmann, SH; Ludeman, SM | 1 |
| Richardson, ME; Siemann, DW | 1 |
| Lee, FY | 1 |
| Jollow, DJ; Peters, RH; Stuart, RK | 1 |
| Ballard, K; Jollow, DJ; Oatis, JE; Peters, RH; Stuart, RK | 1 |
| Chen, G; Waxman, DJ | 1 |
| Dorr, RT; Lagel, K | 1 |
7 other study(ies) available for methionine sulfoximine and perfosfamide
| Article | Year |
|---|---|
Cyclophosphamide resistance in medulloblastoma.
Topics: Aldehyde Dehydrogenase; Buthionine Sulfoximine; Cerebellar Neoplasms; Child; Child, Preschool; Cyclophosphamide; Drug Resistance; gamma-Glutamyltransferase; Glutathione; Glutathione Transferase; Humans; Infant; Male; Medulloblastoma; Methionine Sulfoximine; Sensitivity and Specificity; Tumor Cells, Cultured | 1992 |
Thiol manipulation as a means of overcoming drug resistance in a novel cyclophosphamide-induced resistant cell line.
Topics: Animals; Buthionine Sulfoximine; Cell Survival; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Resistance; Glutathione; In Vitro Techniques; Methionine Sulfoximine; Mice; Tumor Cells, Cultured | 1992 |
Glutathione diminishes the anti-tumour activity of 4-hydroperoxycyclophosphamide by stabilising its spontaneous breakdown to alkylating metabolites.
Topics: Alkylating Agents; Animals; Antimetabolites; Buthionine Sulfoximine; Cyclophosphamide; Drug Synergism; Female; Glutathione; Humans; Intracellular Fluid; Kinetics; Methionine Sulfoximine; Mice; Mice, Inbred Strains; Ovarian Neoplasms; Tumor Cells, Cultured | 1991 |
Role of glutathione in the in vitro synergism between 4-hydroperoxy-cyclophosphamide and cisplatin in leukemia cell lines.
Topics: Animals; Antineoplastic Agents; Buthionine Sulfoximine; Cell Line; Cell Survival; Cisplatin; Cyclophosphamide; Drug Screening Assays, Antitumor; Drug Synergism; Glutathione; Humans; Kinetics; Leukemia; Leukemia, Experimental; Methionine Sulfoximine | 1991 |
Cellular glutathione as a protective agent against 4-hydroperoxycyclophosphamide cytotoxicity in K-562 cells.
Topics: Antimetabolites; Buthionine Sulfoximine; Cell Line; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Interactions; Glutathione; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Methionine Sulfoximine; Sulfhydryl Compounds; Tumor Cells, Cultured | 1990 |
Identification of glutathione S-transferase as a determinant of 4-hydroperoxycyclophosphamide resistance in human breast cancer cells.
Topics: Aldehyde Dehydrogenase; Aldehydes; Breast Neoplasms; Buthionine Sulfoximine; Cell Line; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Resistance; Ethacrynic Acid; Gene Expression Regulation, Enzymologic; Glutathione Transferase; Humans; Methionine Sulfoximine | 1995 |
Effect of sulfhydryl compounds and glutathione depletion on rat heart myocyte toxicity induced by 4-hydroperoxycyclophosphamide and acrolein in vitro.
Topics: Acrolein; Animals; Buthionine Sulfoximine; Cell Survival; Cells, Cultured; Cyclophosphamide; Glutathione; Heart; In Vitro Techniques; Methionine Sulfoximine; Muscle Proteins; Rats; Sulfhydryl Compounds | 1994 |